THE COMPANY/THE MISSION
Changing the Paradigm for Writing DNA
Molecular Assemblies’ leaders detail how the company got started, the company’s technology for synthesizing DNA, and why that technology is better than current methods.
THE TECHNOLOGY, PART 1
Moving Synthetic Biology into the 21st Century
A deeper look at the company’s enzymatic DNA synthesis technology, why it is needed, and the markets it serves.
THE TECHNOLOGY, PART 2
Podcast: The Write Stuff — Reinventing the Synthesis of DNA With Enzymes
Q&A With Molecular Assemblies’ President and CEO Mike Kamdar and Co-Founder and Chief Scientific Officer Bill Efcavitch
Priming to Launch “Oligos as a Service”
Looking towards the year ahead for the company as it prepares to commercialize its synthetic DNAs